Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

AB 54 prohibits the state department from requiring prior authorization or other utilization management controls for FDA-approved antipsychotic prescription drugs under the Medical Assistance program. This directly affects Medicaid beneficiaries who rely on these medications, removing barriers to accessing prescribed antipsychotic treatments. The bill creates a new statute section explicitly stating that utilization management controls (such as step therapy or prior approval) cannot be imposed on these specific drugs. The policy change aims to streamline access to necessary antipsychotic medications without altering drug approval standards.